Status:

RECRUITING

Genetic Susceptibility to Severe Infections

Lead Sponsor:

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

Infectious Disease

Eligibility:

All Genders

Brief Summary

Only a fraction of individuals infected with microbes develop clinical disease. This observation raises fundamental questions about the pathogenesis of infectious diseases. There is a complex interact...

Detailed Description

Justification of the number of subjects: The prevalence of the various severe infections we wish to explore ranges from one case in 50,000 to one case in 1,000,000 individuals; consequently, we plan ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • to sign the informed consent signed by the patient. In the case of a minor patient, consent is signed by the holders of parental authority. In the case of a protected adult patient, the consent is signed by their legal representative. In the case of an adult patient unable to consent at the time of inclusion, consent is signed by a family member.
  • to have a proven rare and severe infection
  • to be hospitalized or followed in a specialized hospital department, in the emergency room or in intensive care
  • to be affiliated to the French Social Security system
  • for relatives, to be related to the index case up to the 3rd degree: Parents, Children, Brother, Sister, Grandparents, Uncles, Aunts, Cousins, Nephews, Nieces
  • Exclusion Criteria
  • to have an acquired immunodeficiency (having received immunosuppressive treatment in the 3 months preceding the onset of the disease or being HIV positive)
  • pregnant woman at the time of illness

Exclusion

    Key Trial Info

    Start Date :

    February 18 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 18 2038

    Estimated Enrollment :

    2000 Patients enrolled

    Trial Details

    Trial ID

    NCT06102070

    Start Date

    February 18 2022

    End Date

    October 18 2038

    Last Update

    March 19 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Centre d'Etudes des Déficits Immunitaires (CEDI), Hôpital Necker-Enfants

    Paris, Île-de-France Region, France, 75015